Optimal Anesthetic Induction for Cardiovascular Patients

Recommended Induction Regimen

The American College of Cardiology recommends combining sevoflurane with remifentanil (0.15-0.25 μg/kg/min) or fentanyl (1-2 μg/kg slow IV) for balanced anesthesia with minimal hemodynamic impact in patients with cardiovascular disease undergoing non-cardiac surgery 1, 2
For maintenance, the American Heart Association suggests continuing sevoflurane (0.5-1 MAC) with opioid infusion to maintain hemodynamic stability 3

Volatile anesthetics like sevoflurane have demonstrated cardioprotective effects, decreasing troponin release and enhancing left ventricular function compared to propofol or midazolam, as stated by the American Heart Association 2
The 2014 ACC/AHA guidelines state that either volatile anesthetic agents or total intravenous anesthesia is reasonable, but volatile agents offer specific cardioprotective benefits 3, 4

The American College of Cardiology suggests that neuraxial anesthesia (epidural) can be beneficial for postoperative pain control and may decrease cardiac events in specific procedures like abdominal aortic surgery 4, 5
The American College of Cardiology recommends avoiding prophylactic intravenous nitroglycerin as it is not effective in reducing myocardial ischemia and may lead to cardiovascular decompensation through decreases in preload 5, 6, 7
The American Heart Association suggests considering transesophageal echocardiography for monitoring in cases of hemodynamic instability, but routine use is not recommended 3, 5
Maintaining normothermia is recommended to potentially reduce perioperative cardiac events, as stated by the American Heart Association 3

The American Heart Association warns against excessive fluid administration to counteract anesthetic-induced hypotension, as this may lead to fluid overload in patients with compromised cardiac function 2
The American College of Cardiology notes that opioid-based anesthetics provide cardiovascular stability but high doses may require prolonged postoperative ventilation 8

The American Heart Association and American College of Cardiology recommend sevoflurane as a reasonable choice for anesthetic induction in patients with left ventricular dysfunction, as it provides better hemodynamic stability compared to most intravenous anesthetics and may offer myocardial protective effects 9, 10

In patients with left ventricular dysfunction (ejection fraction < 50%), sevoflurane has been shown to decrease troponin release and improve left ventricular function compared to propofol, with a moderate strength of evidence 11, 12

Volatile anesthetics like sevoflurane have been demonstrated to decrease troponin release in 6 trials, preserve early left ventricular function in 5 trials, decrease ICU length of stay, and decrease late cardiac events in 1 trial, with a high strength of evidence 9, 11, 12
Sevoflurane has been shown to precondition and postcondition the heart against infarction by activating specific intracellular signal transduction pathways, with a moderate strength of evidence 9, 12

The American Heart Association recommends starting with low concentrations (0.25-0.5 MAC) of sevoflurane and gradually increasing to minimize hemodynamic fluctuations, with a high strength of evidence 9, 10

The 2024 AHA/ACC guidelines note that several studies have failed to identify significant advantages of inhaled versus intravenous anesthesia for non-cardiac surgery, but acknowledge the established benefits of sevoflurane in cardiac surgery patients and those with reduced ejection fraction, with a moderate strength of evidence 13, 14